1. Silencing of CCR4-NOT complex subunits affects heart structure and function
- Author
-
Anaïs Kervadec, Karen Ocorr, Sreehari Kalvakuri, Rolf Bodmer, Santiago Pineda, Andrew A. Hicks, Claudia B. Volpato, Anthony Cammarato, Lisa Elmén, Peter P. Pramstaller, Nakissa N. Alayari, Alexandre R. Colas, Luisa Foco, and Alessandra Rossini
- Subjects
0301 basic medicine ,Medicine (miscellaneous) ,lcsh:Medicine ,Action Potentials ,030204 cardiovascular system & hematology ,Long-QT syndrome ,hiPSC ,Animals, Genetically Modified ,0302 clinical medicine ,Immunology and Microbiology (miscellaneous) ,Heart Rate ,Drosophila heart ,Gene expression ,Morphogenesis ,Drosophila Proteins ,GWAS ,Myocytes, Cardiac ,Cardiomyocytes ,Gene knockdown ,Heart development ,Intracellular Signaling Peptides and Proteins ,Gene Expression Regulation, Developmental ,RNA-Binding Proteins ,Cell biology ,Long QT Syndrome ,Drosophila melanogaster ,Arrhythmia ,lcsh:RB1-214 ,Research Article ,Induced Pluripotent Stem Cells ,Neuroscience (miscellaneous) ,Biology ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Ribonucleases ,CCR4-NOT complex ,lcsh:Pathology ,Gene silencing ,Animals ,Humans ,Gene Silencing ,Gene ,Cell Proliferation ,Messenger RNA ,lcsh:R ,Promoter ,Dros ,Repressor Proteins ,030104 developmental biology ,Exoribonucleases ,CNOT1 ,Genome-Wide Association Study ,HeLa Cells ,Transcription Factors - Abstract
The identification of genetic variants that predispose individuals to cardiovascular disease and a better understanding of their targets would be highly advantageous. Genome-wide association studies have identified variants that associate with QT-interval length (a measure of myocardial repolarization). Three of the strongest associating variants (single-nucleotide polymorphisms) are located in the putative promotor region of CNOT1, a gene encoding the central CNOT1 subunit of CCR4-NOT: a multifunctional, conserved complex regulating gene expression and mRNA stability and turnover. We isolated the minimum fragment of the CNOT1 promoter containing all three variants from individuals homozygous for the QT risk alleles and demonstrated that the haplotype associating with longer QT interval caused reduced reporter expression in a cardiac cell line, suggesting that reduced CNOT1 expression might contribute to abnormal QT intervals. Systematic siRNA-mediated knockdown of CCR4-NOT components in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) revealed that silencing CNOT1 and other CCR4-NOT genes reduced their proliferative capacity. Silencing CNOT7 also shortened action potential duration. Furthermore, the cardiac-specific knockdown of Drosophila orthologs of CCR4-NOT genes in vivo (CNOT1/Not1 and CNOT7/8/Pop2) was either lethal or resulted in dilated cardiomyopathy, reduced contractility or a propensity for arrhythmia. Silencing CNOT2/Not2, CNOT4/Not4 and CNOT6/6L/twin also affected cardiac chamber size and contractility. Developmental studies suggested that CNOT1/Not1 and CNOT7/8/Pop2 are required during cardiac remodeling from larval to adult stages. To summarize, we have demonstrated how disease-associated genes identified by GWAS can be investigated by combining human cardiomyocyte cell-based and whole-organism in vivo heart models. Our results also suggest a potential link of CNOT1 and CNOT7/8 to QT alterations and further establish a crucial role of the CCR4-NOT complex in heart development and function. This article has an associated First Person interview with the first author of the paper., Summary: Genome-wide association studies combined with in vitro human cardiac cell assays and a model organism suitable for heart studies in vivo connect CNOT1, CNOT7 and overall the CCR4-NOT complex to human heart disease and morbidity.
- Published
- 2020